Human Caspase-7 quantitates human Caspase-7 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Caspase-7.
Human Caspase-7 quantitates human Caspase-7 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Caspase-7.
Human Caspase-7 quantitates human Caspase-7 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Caspase-7.
Caspase 7 is a member of a family of cysteine proteases that can be divided into subfamilies of apoptotic and inflammatory caspase. Unlike apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. The apoptotic subfamily can be divided into initiatory caspases, which are activated in response to death signals, and in performing caspases, which are activated by initiatory caspases and are responsible for the cleavage of cell substrates that ultimately lead to cell death. Caspase 7 is a performing caspase that has been identified by its homology with caspases 1 and 3, as well as the cell death protein of C. elegans CED-3. The alternative splicing of caspase-7 mRNA results in the production of 3 distinct isoforms. Caspase-7 activity can be inhibited directly by XIAP expression. Alternative splicing leads to four transcription variants, coding three distinct isoforms from caspase 7. Diseases associated with CASP7 include Type 1 diabetes mellitus 17 and Mink's aleutian disease.
Sensitivity
Sensitivity of the dosage: 0.62 ng/ml.
Measurement range
Dose range: 0.62 to 150 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Caspase 7.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).